Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Shares Outstanding (Weighted Average) (2016 - 2023)

Historic Shares Outstanding (Weighted Average) for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to $285886.0.

  • Aptevo Therapeutics' Shares Outstanding (Weighted Average) fell 9438.4% to $285886.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $285886.0, marking a year-over-year decrease of 9438.4%. This contributed to the annual value of $5.1 million for FY2022, which is 879.61% up from last year.
  • Aptevo Therapeutics' Shares Outstanding (Weighted Average) amounted to $285886.0 in Q3 2023, which was down 9438.4% from $163425.0 recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $5.1 million in Q4 2022 and a low of $159597.0 during Q1 2023
  • For the 5-year period, Aptevo Therapeutics' Shares Outstanding (Weighted Average) averaged around $3.3 million, with its median value being $3.3 million (2020).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 10785.79% in 2020, then plummeted by 9676.76% in 2023.
  • Aptevo Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $2.9 million in 2019, then grew by 16.25% to $3.4 million in 2020, then surged by 38.25% to $4.7 million in 2021, then rose by 8.8% to $5.1 million in 2022, then crashed by 94.39% to $285886.0 in 2023.
  • Its Shares Outstanding (Weighted Average) was $285886.0 in Q3 2023, compared to $163425.0 in Q2 2023 and $159597.0 in Q1 2023.